维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

12篇 您的检索式：作者名="Shalinsky DR"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials显示文摘	Shalinsky DR Brekken J Zou H	1999	Ann N Y Acad Sci1999，878，2：	1
	2	Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials显示文摘	Shalinsky DR Brekken J Zou H	1999	Ann Neo York Acad Sci1999，878，：	1
	3	Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials显示文摘	Shalinsky DR Brekken J Zou H	1999	Ann N Y Acad Sci1999，878，：	1
	4	Marked antiangiogenic and antiumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumours: single agent and combination therapy studies 显示文摘	Brekken J Zou H	1999	Clin Cancer Res1999，5，7：	1
	5	Broad antitumor and antiangiogenic activities of AG3340,a potent and selective MMP inhibitor undergoing advanced oncology clinical trials显示文摘	Brekken J Zou H	1999	Ann N Y Acad Sci1999，878，2：	1
	6	Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials 显示文摘	Shalinsky DR Brekken J Zoh H	1999	Ann N Y Acad Sci1999，878，：	1
	7	Inhibition of GSH-dependent PGH2 isomerase in mammary adenocarcinoma cells by alliein显示文摘	Shalinsky DR McNamara DB Agrawal KC	1989	Prostaglandins1989，37，：	1
	8	Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies显示文摘	Shalinsky DR Brekken J Rerren J	1999	Clin Cancer Res1999，5，3：	1
	9	Marked inhibition of the proliferation of human adenocarcinoma colon tumors in vivo by orally-administated AG3340, a novel matrix metalloproteinase(MMP) inhibitor 显示文摘	Shalinsky DR Brekken J Robinson SR	1998	Proc Am Assoc Cancer Res1998，39，5：	1
	10	Broad antitumor and antiangiogenic activies of AG3340,a potent and selective MMP inhibitor undergoing advanced oncology clinical trials显示文摘	Brekken J Zou H	1999	Ann N Y Acad Sci1999，878，：	1
	11	Broad antitumor and antiangiogeni c activities of AG3340, a potent and selective MMP inhibitor undergiong advanced oncology clinical trials显示文摘	Brekken J Zou H	1999	Ann NY Acad Sci1999，878，6：	1
	12	Broad anfitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials 显示文摘	Shalinsky DR Brekken J Zoh H	1999	Ann N Y Acad Sci1999，878，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费